T2 Biosystems, Inc. (TTOO)
| Market Cap | 144.62M |
| Revenue (ttm) | 26.68M |
| Net Income (ttm) | -44.30M |
| Shares Out | 154.89M |
| EPS (ttm) | -0.30 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,401,908 |
| Open | 0.880 |
| Previous Close | 0.878 |
| Day's Range | 0.855 - 0.888 |
| 52-Week Range | 0.810 - 3.790 |
| Beta | 0.29 |
| Analysts | Strong Buy |
| Price Target | 2.20 (+152.3%) |
| Est. Earnings Date | Nov 4, 2021 |
About TTOO
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. It provides T2 Magnetic Resonance technology that enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument for detecting pathogens associated with sepsis and Lyme disease, and other applications,...
Financial Performance
In 2020, T2 Biosystems's revenue was $18.13 million, an increase of 117.52% compared to the previous year's $8.34 million. Losses were -$46.80 million, -20.69% less than in 2019.
Financial StatementsAnalyst Forecast
According to 4 analysts, the average rating for T2 Biosystems stock is "Strong Buy." The 12-month stock price forecast is 2.20, which is an increase of 152.29% from the latest price.
News
3 Hot Penny Stocks for Friday: What's Going on With TTOO, SALM and GROM Today?
Investors are tracking hot penny stocks that are on the move today with a few names getting quite a bit of attention on Friday. The post 3 Hot Penny Stocks for Friday: What's Going on With TTOO, SALM an...
T2 Biosystems to Report Third Quarter 2021 Financial Results on November 4, 2021
LEXINGTON, Mass., Oct. 22, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results ...
T2 Biosystems Announces Distribution Agreements in Key Asia-Pacific Markets
Expands International Commercialization with Initial Shipment of T2Dx Instruments to Asia Expands International Commercialization with Initial Shipment of T2Dx Instruments to Asia
T2 Biosystems Appoints Laura Adams to Its Board of Directors
LEXINGTON, Mass., Oct. 19, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the appointment of Laura Adams to its ...
T2 Biosystems Reports Granting of Inducement Award
LEXINGTON, Mass., Oct. 15, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards to twe...
T2 Biosystems Showcases Research from Recent Industry Conferences
Leading rapid diagnostics company shares highlights of comprehensive data presented at AACC, CAP21 and IDWeek Leading rapid diagnostics company shares highlights of comprehensive data presented at AACC,...
T2 Biosystems Announces BARDA Exercise of Contract Option 2A Valued at $6.4 Million
Advances Development of Diagnostics for Sepsis-Causing Pathogens, Antibiotic Resistance, and Biothreat Pathogens Advances Development of Diagnostics for Sepsis-Causing Pathogens, Antibiotic Resistance, ...
T2 Biosystems to Unveil New Data at September Conferences
Leading rapid diagnostics company to share new research at industry conferences throughout Sepsis Awareness Month Leading rapid diagnostics company to share new research at industry conferences througho...
Are Options Traders Betting on a Big Move in T2 Biosystems (TTOO) Stock?
Investors need to pay close attention to T2 Biosystems (TTOO) stock based on the movements in the options market lately.
TTOO Stock: The Huge Covid-19 News Lifting T2 Biosystems Today
T2 Biosystems has announced a breakthrough in Covid-19 variant testing. As a result, shares have rapidly shot up.
T2 Biosystems' Stock Jumps As Its COVID-19 Molecular Test Can Detect Mu, Iota Variants
T2 Biosystems Inc (NASDAQ:TTOO) announced that its T2SARS-CoV-2 Panel is capable of detecting the Mu (B.1.621) and Iota (B.1.526) variants, which were recently confirmed to be present in the U.S. Also R...
T2 Biosystems T2SARS-CoV-2™ Panel Proves Capable of Detecting the Mu B.1.621 and Iota B.1.526 Variants of the SARS-Co...
LEXINGTON, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that its T2SARS-CoV-2™ Panel—a molecu...
T2 Biosystems Announces Plans to Consolidate and Expand Facilities in Massachusetts
LEXINGTON, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today plans to consolidate its existing fac...
T2 Biosystems Recognizes Sepsis Awareness Month with Thought Leadership Campaign and Participation in Sepsis Alliance...
Leading rapid diagnostics company aims to increase awareness of sepsis diagnosis, management and treatment Leading rapid diagnostics company aims to increase awareness of sepsis diagnosis, management an...
T2 Biosystems Q2 Earnings Edges Wall Street Estimates On Higher Test Panels Volumes, Expects Lower COVID-19 Test Sale...
T2 Biosystems Inc's (NASDAQ: TTOO) second-quarter revenues rose 162% Y/Y to $6.7 million, slightly ahead of the consensus of $6.12 million, primarily due to increased test panel sales. The firm reported...
T2 Biosystems (TTOO) Reports Q2 Loss, Tops Revenue Estimates
T2 Biosystems (TTOO) delivered earnings and revenue surprises of 0.00% and 12.13%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
T2 Biosystems to Participate in the Canaccord Genuity 41st Annual Growth Conference
LEXINGTON, Mass., Aug. 04, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced plans to participate in the upcoming C...
Will T2 Biosystems (TTOO) Report Negative Earnings Next Week? What You Should Know
T2 Biosystems (TTOO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
T2 Biosystems to Report Second Quarter 2021 Financial Results on August 5, 2021
LEXINGTON, Mass., July 22, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results ...
T2 Biosystems Reports Granting of Inducement Award
LEXINGTON, Mass., July 19, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards to ele...
8 Reddit Penny Stocks to Watch With Meme Stocks on the Rise
Best penny stocks to watch on Reddit with meme stocks on the rise? Check these 8 out The post 8 Reddit Penny Stocks to Watch With Meme Stocks on the Rise appeared first on Penny Stocks to Buy, Picks, Ne...
Trending Penny Stocks to Buy Right Now? 8 For Your Watchlist
Are these trending penny stocks worth watching in July 2021? The post Trending Penny Stocks to Buy Right Now?
T2 Biosystems to Participate at Clinical Conferences in June and July 2021
Company will underscore the importance of rapid diagnostic technology for detecting bloodstream infections (BSIs) and sepsis Company will underscore the importance of rapid diagnostic technology for det...
World's Leading Proxy Advisory Firms ISS and Glass Lewis Recommend T2 Biosystems Stockholders Vote “FOR” the Charter ...
LEXINGTON, Mass., June 11, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that leading proxy advisory firms Inst...
Hot Biotech Penny Stocks To Buy? 3 to Watch Right Now
With biotech penny stocks back in focus, which small-caps are you watching? The post Hot Biotech Penny Stocks To Buy?